2014
$85M
from 6 investors over 6 rounds
Zentalis Pharmaceuticals raised $85M on December 9, 2019
Investors: Perceptive Advisors, Redmile Group, Surveyor Capital, Viking Global Investors and Eventide Asset Management
Zentalis Pharmaceuticals raised $34M on December 1, 2017
Investors: Viking Global Investors